Gregg Duncan, Ph.D.
University of Maryland, College Park, MD
Engineering a clinically implemented nanoparticle-based mucus diagnostic for chronic lung diseases
Obstructive lung diseases such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease affect millions worldwide and there has been little innovation in diagnostics made available to assess these patients. Given the limited options, we propose to use nanotechnology in the design of a novel diagnostic tool to monitor physical changes in mucus associated with the progression of disease. The proposed research offers a new, highly valuable means to diagnose patients and potentially improve clinical outcomes for those with these chronic lung diseases.
Sign up for the latest lung health news sent right to your inbox.
Join more than 500,000 people who receive research updates, inspiring stories, health information and more.